Skip to main content
Erschienen in: Pediatric Nephrology 8/2016

26.02.2016 | Original Article

Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease

verfasst von: Priyanka Khandelwal, Vijaya Murugan, Smriti Hari, Ramakrishnan Lakshmy, Aditi Sinha, Pankaj Hari, Arvind Bagga

Erschienen in: Pediatric Nephrology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic kidney disease (CKD) predisposes to accelerated atherosclerosis that is measured by carotid artery intima-media thickness (cIMT) and brachial artery flow-mediated dilation (FMD). Information on the association of these parameters with dyslipidemia in pre-dialysis pediatric CKD is limited.

Methods

Eighty patients aged 9.9 ± 3.2 years, with estimated glomerular filtration rate of 38.8 ± 10.8 ml/1.73 m2/min, and 42 pediatric controls underwent cross-sectional analysis of lipid profile, cIMT, and brachial artery FMD. Significant differences in these parameters between patients and controls were analyzed using Student’s t test. Predictors of cIMT and dyslipidemia were assessed using linear and logistic regression respectively.

Results

Patients had elevated blood levels of triglyceride and of total and LDL cholesterol than controls (P ≤ 0.001); 73.8 % were dyslipidemic. Mean cIMT was higher (0.421 ± 0.054 mm vs 0.388 ± 0.036 mm, P = 0.001) and brachial artery FMD was reduced (10.6 ± 4.9 % vs 18.9 ± 4.1 %, P < 0.0001) in patients compared with controls. On multivariate analysis, hypertension (OR 3.68, P = 0.044) and male gender (OR 10.21, P = 0.004) were associated with dyslipidemia; cIMT was significantly associated with LDL cholesterol (β = 28.36, P = 0.033).

Conclusion

Dyslipidemia was prevalent and cIMT significantly elevated in pre-dialysis pediatric CKD, indicating increased cardiovascular risk. Elevated LDL cholesterol predicted increased cIMT, strengthening the association between dyslipidemia and atherosclerosis in early CKD.
Literatur
2.
Zurück zum Zitat Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128 [Suppl 5]:S213–S256PubMedCentral Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128 [Suppl 5]:S213–S256PubMedCentral
3.
Zurück zum Zitat McGill HC Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC, Strong JP (2000) Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 20:1998–2004CrossRefPubMed McGill HC Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC, Strong JP (2000) Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 20:1998–2004CrossRefPubMed
4.
Zurück zum Zitat Shroff R, Degi A, Kerti A, Kis E, Cseprekal O, Tory K, Szabo AJ, Reusz GS (2013) Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol 28:875–884CrossRefPubMed Shroff R, Degi A, Kerti A, Kis E, Cseprekal O, Tory K, Szabo AJ, Reusz GS (2013) Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol 28:875–884CrossRefPubMed
5.
Zurück zum Zitat Fried LF, Orchard TJ, Kasiske BL (2001) Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 59:260–269CrossRefPubMed Fried LF, Orchard TJ, Kasiske BL (2001) Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 59:260–269CrossRefPubMed
6.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed
7.
Zurück zum Zitat Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol 16:2796–2803CrossRefPubMed Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol 16:2796–2803CrossRefPubMed
8.
Zurück zum Zitat Litwin M, Wuhl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F (2008) Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23:2552–2557CrossRefPubMed Litwin M, Wuhl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F (2008) Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23:2552–2557CrossRefPubMed
9.
Zurück zum Zitat Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, Boden-Albala B, Sacco R, Homma S (2007) The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 192:197–203CrossRefPubMed Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, Boden-Albala B, Sacco R, Homma S (2007) The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 192:197–203CrossRefPubMed
10.
Zurück zum Zitat Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467CrossRefPubMed Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467CrossRefPubMed
11.
Zurück zum Zitat Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950CrossRefPubMed Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950CrossRefPubMed
12.
Zurück zum Zitat Muscheites J, Meyer AA, Drueckler E, Wigger M, Fischer DC, Kundt G, Kienast W, Haffner D (2008) Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol 23:2233–2239CrossRefPubMed Muscheites J, Meyer AA, Drueckler E, Wigger M, Fischer DC, Kundt G, Kienast W, Haffner D (2008) Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol 23:2233–2239CrossRefPubMed
13.
Zurück zum Zitat Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996–3003CrossRefPubMed Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996–3003CrossRefPubMed
14.
Zurück zum Zitat Enas EA, Singh V, Munjal YP, Bhandari S, Yadave RD, Manchanda SC (2008) Reducing the burden of coronary artery disease in India: challenges and opportunities. Indian Heart J 60:161–175PubMed Enas EA, Singh V, Munjal YP, Bhandari S, Yadave RD, Manchanda SC (2008) Reducing the burden of coronary artery disease in India: challenges and opportunities. Indian Heart J 60:161–175PubMed
15.
Zurück zum Zitat Hari P, Singla IK, Mantan M, Kanitkar M, Batra B, Bagga A (2003) Chronic renal failure in children. Indian Pediatr 40:1035–1042PubMed Hari P, Singla IK, Mantan M, Kanitkar M, Batra B, Bagga A (2003) Chronic renal failure in children. Indian Pediatr 40:1035–1042PubMed
16.
Zurück zum Zitat Wilson AC, Schneider MF, Cox C, Greenbaum LA, Saland J, White CT, Furth S, Warady BA, Mitsnefes MM (2011) Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease. Clin J Am Soc Nephrol 6:2759–2765CrossRefPubMedPubMedCentral Wilson AC, Schneider MF, Cox C, Greenbaum LA, Saland J, White CT, Furth S, Warady BA, Mitsnefes MM (2011) Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease. Clin J Am Soc Nephrol 6:2759–2765CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, Warady BA, Furth SL, CKiD Investigators (2010) Dyslipidemia in children with chronic kidney disease. Kidney Int 78:1154–1163CrossRefPubMedPubMedCentral Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, Warady BA, Furth SL, CKiD Investigators (2010) Dyslipidemia in children with chronic kidney disease. Kidney Int 78:1154–1163CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, White CT, Furth S, Warady BA, Mitsnefes M (2012) Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol 7:1930–1937CrossRefPubMedPubMedCentral Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, White CT, Furth S, Warady BA, Mitsnefes M (2012) Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol 7:1930–1937CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522–526CrossRefPubMed Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522–526CrossRefPubMed
20.
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266
21.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150CrossRef
22.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497CrossRef
23.
Zurück zum Zitat De Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85:660–667CrossRefPubMedPubMedCentral De Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85:660–667CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef
25.
Zurück zum Zitat Wentz PW, Cross RE, Savory J (1976) An integrated approach to lipid profiling: enzymatic determination of cholesterol and triglycerides with a centrifugal analyzer. Clin Chem 22:188–192PubMed Wentz PW, Cross RE, Savory J (1976) An integrated approach to lipid profiling: enzymatic determination of cholesterol and triglycerides with a centrifugal analyzer. Clin Chem 22:188–192PubMed
26.
Zurück zum Zitat Steele BW, Koehler DF, Azar MM, Blaszkowski TP, Kuba K, Dempsey ME (1976) Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin Chem 22:98–101PubMed Steele BW, Koehler DF, Azar MM, Blaszkowski TP, Kuba K, Dempsey ME (1976) Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin Chem 22:98–101PubMed
27.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
28.
Zurück zum Zitat Daniels SR, Greer FR, Committee on Nutrition (2008) Lipid screening and cardiovascular health in childhood. Pediatrics 122:198–208CrossRefPubMed Daniels SR, Greer FR, Committee on Nutrition (2008) Lipid screening and cardiovascular health in childhood. Pediatrics 122:198–208CrossRefPubMed
29.
Zurück zum Zitat Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS (2012) Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290–296CrossRefPubMedPubMedCentral Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS (2012) Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290–296CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International brachial artery reactivity task force. J Am Coll Cardiol 39:257–265CrossRefPubMed Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International brachial artery reactivity task force. J Am Coll Cardiol 39:257–265CrossRefPubMed
31.
Zurück zum Zitat Saland JM, Ginsberg HN (2007) Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 22:1095–1112CrossRefPubMed Saland JM, Ginsberg HN (2007) Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 22:1095–1112CrossRefPubMed
32.
Zurück zum Zitat Khurana M, Silverstein DM (2015) Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease. Pediatr Nephrol 30:2073–2084CrossRefPubMed Khurana M, Silverstein DM (2015) Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease. Pediatr Nephrol 30:2073–2084CrossRefPubMed
33.
Zurück zum Zitat Papadopoulou ZL, Sandler P, Tina LU, Jose PA, Calcagno PL (1981) Hyperlipidemia in children with chronic renal insufficiency. Pediatr Res 15:887–891CrossRefPubMed Papadopoulou ZL, Sandler P, Tina LU, Jose PA, Calcagno PL (1981) Hyperlipidemia in children with chronic renal insufficiency. Pediatr Res 15:887–891CrossRefPubMed
35.
Zurück zum Zitat Tunon J, Martin-Ventura JL, Blanco-Colio LM, Tarin N, Egido J (2007) Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors. Vasc Health Risk Manag 3:521–526PubMedPubMedCentral Tunon J, Martin-Ventura JL, Blanco-Colio LM, Tarin N, Egido J (2007) Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors. Vasc Health Risk Manag 3:521–526PubMedPubMedCentral
36.
Zurück zum Zitat Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP, Collatina S, Pahor M (1999) Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 34:1281–1286CrossRefPubMed Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP, Collatina S, Pahor M (1999) Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 34:1281–1286CrossRefPubMed
37.
Zurück zum Zitat Kotur-Stevuljević J, Peco-Antic A, Spasic S, Stefanovic A, Paripovic D, Kostic M, Vasic D, Vujovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Kornic-Ristovski D (2013) Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease. Pediatr Nephrol 28:295–303CrossRefPubMed Kotur-Stevuljević J, Peco-Antic A, Spasic S, Stefanovic A, Paripovic D, Kostic M, Vasic D, Vujovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Kornic-Ristovski D (2013) Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease. Pediatr Nephrol 28:295–303CrossRefPubMed
38.
Zurück zum Zitat Sozeri B, Mir S, Kara OD, Levent E (2010) When does the cardiovascular disease appear in patients with chronic kidney disease? Pediatr Cardiol 31:821–828CrossRefPubMed Sozeri B, Mir S, Kara OD, Levent E (2010) When does the cardiovascular disease appear in patients with chronic kidney disease? Pediatr Cardiol 31:821–828CrossRefPubMed
39.
Zurück zum Zitat Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF (2014) HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 5:CD007784PubMed Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF (2014) HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 5:CD007784PubMed
40.
Zurück zum Zitat Hou W, Lv J, Perkovic V, Yang L, Zhao N, Jardine MJ, Cass A, Zhang H, Wang H (2013) Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J 34:1807–1817CrossRefPubMed Hou W, Lv J, Perkovic V, Yang L, Zhao N, Jardine MJ, Cass A, Zhang H, Wang H (2013) Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J 34:1807–1817CrossRefPubMed
41.
Zurück zum Zitat Hussein G, Bughdady Y, Kandil ME, Bazaraa HM, Taher H (2008) Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr Nephrol 23:2025–2030CrossRefPubMed Hussein G, Bughdady Y, Kandil ME, Bazaraa HM, Taher H (2008) Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr Nephrol 23:2025–2030CrossRefPubMed
42.
Zurück zum Zitat Donin AS, Nightingale CM, Owen CG, Rudnicka AR, McNamara MC, Prynne CJ, Stephen AM, Cook DG, Whincup PH (2010) Ethnic differences in blood lipids and dietary intake between UK children of black African, black Caribbean, South Asian, and white European origin: the Child Heart and Health Study in England (CHASE). Am J Clin Nutr 92:776–783CrossRefPubMed Donin AS, Nightingale CM, Owen CG, Rudnicka AR, McNamara MC, Prynne CJ, Stephen AM, Cook DG, Whincup PH (2010) Ethnic differences in blood lipids and dietary intake between UK children of black African, black Caribbean, South Asian, and white European origin: the Child Heart and Health Study in England (CHASE). Am J Clin Nutr 92:776–783CrossRefPubMed
43.
Zurück zum Zitat Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494–1500CrossRefPubMed Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494–1500CrossRefPubMed
44.
Zurück zum Zitat Ziolkowska H, Brzewski M, Roszkowska-Blaim M (2008) Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol 23:805–811CrossRefPubMed Ziolkowska H, Brzewski M, Roszkowska-Blaim M (2008) Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol 23:805–811CrossRefPubMed
45.
Zurück zum Zitat Canpolat N, Caliskan S, Sever L, Guzeltas A, Kantarci F, Candan C, Civilibal M, Kasapcopur O, Arisoy N (2012) Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease? Pediatr Nephrol 27:627–635CrossRefPubMed Canpolat N, Caliskan S, Sever L, Guzeltas A, Kantarci F, Candan C, Civilibal M, Kasapcopur O, Arisoy N (2012) Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease? Pediatr Nephrol 27:627–635CrossRefPubMed
46.
Zurück zum Zitat Makulska I, Szczepanska M, Drozdz D, Polak-Jonkisz D, Zwolinska D (2015) Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease. Pediatr Nephrol 30:811–819CrossRefPubMed Makulska I, Szczepanska M, Drozdz D, Polak-Jonkisz D, Zwolinska D (2015) Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease. Pediatr Nephrol 30:811–819CrossRefPubMed
Metadaten
Titel
Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease
verfasst von
Priyanka Khandelwal
Vijaya Murugan
Smriti Hari
Ramakrishnan Lakshmy
Aditi Sinha
Pankaj Hari
Arvind Bagga
Publikationsdatum
26.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 8/2016
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-016-3350-4

Weitere Artikel der Ausgabe 8/2016

Pediatric Nephrology 8/2016 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.